Beyond the Tools: Leading Healthcare Commercialization in the Age of Artificial Intelligence

A group of experts explore the advantages of purpose-built artificial intelligence (AI) for healthcare over generic models.

Zoe Lazarra, Claudia Ciciliano, and Shankar Narayanan assess where artificial intelligence (AI) is already proving its value in pharma commercialization and where to go next.

Experts consider what happens when artificial intelligence (A) tools multiply faster than organizations can connect them.